Diode Laser Treatment of Bladder Tumors
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02738827|
Recruitment Status : Completed
First Posted : April 14, 2016
Last Update Posted : May 31, 2017
Laser treatment of pTa low grade bladder tumours in the outpatient department
Number of Subjects/Centres Planned: 20 patients will be included in this study. The study will be performed at Department of Urology, Bispebjerg-Frederiksberg Hospital, Copenhagen, Denmark.
Primary Objective: To show that small pTa bladder tumours safely can be removed with diode laser in an outpatient department Secondary Objective: To evaluate the patients experience with the laser treatment using QOL questionaires (symptom evaluation) and Visual Analog Scale Score (pain evaluation).
|Condition or disease||Intervention/treatment||Phase|
|Bladder Cancer||Procedure: Laser treatment||Not Applicable|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||21 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Diode Laser Treatment of Pta Low Grade Bladder Tumors in the Outpatient Department.|
|Study Start Date :||November 2015|
|Actual Primary Completion Date :||February 1, 2017|
|Actual Study Completion Date :||March 1, 2017|
Intervention is diode laser treatment of bladder cancer through a cystoscope without sedation of the patient.
Procedure: Laser treatment
Intervention is diode laser treatment of bladder cancer through a cystoscope in the outpatient department
- Tumour clearance [ Time Frame: 1 month ]No bladder tumor tissue in biopsies obtained from areas where a bladder tumor one month earlier has been removed by use of diode laser.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02738827
|Urological department, Frederiksberg Hospital|
|Copenhagen, Denmark, 2000|
|Principal Investigator:||Gregers G Hermann, MD||Dept Urology, Herlev/Gentofte hospital, Copenhagen, Denmark|